Boards of directors -- Developing countries : Enhancing board effectiveness : institutional, regulatory, and functional perspectives for developing and emerging markets / edited by Franklin N. Ngwu, Onyeka K. Osuji, Chris Ogbechie, and David Williamson
Boards of directors -- European Union countries : Corporate governance in a globalising world : convergence or divergence? ; A European perspective / by Lutgart Van den Berghe in collaboration with Christoph Van der Elst, Steven Carchon, Abigail Levrau
Boards of directors -- Textbooks : Guidelines for improving the effectiveness of boards of directors of nonprofit organizations / Dr. Vic Murray, Dr. Yvonne Harrison
Boards of trade -- Europe : Chambers of commerce in Europe : self-governance and institutional change / Detlef Sack, editor
2021
1
Boards of trade -- Germany : The German Chambers of Commerce and Industry : self-governance, service, the general representation of interests and the dual system of professional education / Eberhard Sasse, Andre Habisch, editors
2021
1
Boards of trade -- Great Britain -- History : Local business voice : the history of Chambers of Commerce in Britain, Ireland, and revolutionary America, 1760-2011 / Robert J. Bennett
2011
1
Boards of trade -- Ireland -- History : Local business voice : the history of Chambers of Commerce in Britain, Ireland, and revolutionary America, 1760-2011 / Robert J. Bennett
Boards of trade -- United States -- History : Local business voice : the history of Chambers of Commerce in Britain, Ireland, and revolutionary America, 1760-2011 / Robert J. Bennett
Committees established to review interim data and efficacy outcomes in clinical trials. The findings of these committees are used in deciding whether a trial should be continued as designed, changed, or terminated. Government regulations regarding federally-funded research involving human subjects (the "Common Rule") require (45 CFR 46.111) that research ethics committees reviewing large-scale clinical trials monitor the data collected using a mechanism such as a data monitoring committee. FDA regulations (21 CFR 50.24) require that such committees be established to monitor studies conducted in emergency settings